BIO-key International (NASDAQ:BKYI) Upgraded to Hold at Zacks Research

Zacks Research upgraded shares of BIO-key International (NASDAQ:BKYI – Free Report) to a hold rating in a research report sent to investors on Thursday morning,Zacks.com reports.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a report on Friday, July 17th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, BIO-key International has a consensus rating of “Reduce”.

Get BIO-key International alerts:

Check Out Our Latest Stock Report on BKYI

BIO-key International Price Performance

NASDAQ BKYI opened at $4.03 on Thursday. BIO-key International has a fifty-two week low of $3.10 and a fifty-two week high of $19.70. The stock’s 50-day moving average is $4.40 and its two-hundred day moving average is $5.31. The firm has a market cap of $4.39 million, a P/E ratio of -0.73 and a beta of 0.44.

Institutional Trading of BIO-key International

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC increased its position in BIO-key International Inc. (NASDAQ:BKYI – Free Report) by 49.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 48,892 shares of the technology company’s stock after acquiring an additional 16,271 shares during the quarter. Geode Capital Management LLC owned about 0.45% of BIO-key International worth $26,000 at the end of the most recent quarter. Institutional investors and hedge funds own 26.51% of the company’s stock.

About BIO-key International

(Get Free Report)

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.

Recommended Stories

• Five stocks we like better than BIO-key International
• MarketBeat Week in Review – 08/03 – 08/07
• Datadog’s Drop Says More About Expectations Than Earnings
• D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
• Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.